| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/06/2009 | CN100484526C Compounding method of cefpirome sulfate raw material and uses thereof |
| 05/06/2009 | CN100484525C Pantoprazole sodium freeze-dried powder injection and preparing method thereof |
| 05/06/2009 | CN100484523C Chinese medicinal preparation of sedum extract and preparation process thereof |
| 05/06/2009 | CN100484521C A nano emulation antibacterial medicine of furacillin and preparation method thereof |
| 05/06/2009 | CN100484520C 5-aminoketone valerate externally-applied preparation and production thereof |
| 05/06/2009 | CN100484519C Ginseng and aconite tablet for injection use for treating qi vacuity and yang desertion and its preparation method |
| 05/06/2009 | CN100484518C Dosage form for providing ascending dose of drug |
| 05/06/2009 | CN100484517C Smash-resisting panax notoginseng total saponin free-dried powdery injection and its preparation |
| 05/06/2009 | CN100484516C Cefamandole nafate powder injection, production method of powder injection and raw machine thereof |
| 05/06/2009 | CN100484515C Guacetisal dry-mixing suspending agents and method of preparing the same |
| 05/06/2009 | CN100484514C Injection medication of emu oil for antiinflammation and ease pain, and preparation method |
| 05/06/2009 | CN100484513C Grafted nano carbon mixed suspension and its preparing process |
| 05/06/2009 | CN100484512C Method for preparing high oxygen large transfusion fluid |
| 05/05/2009 | US7528180 Aqueous medium, a pigment and a dispersant (amphiphilic block copolymer) for dispersing the pigment; for use in recording of color images and for storage of recorded images, use in high-quality gradation recording |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7527809 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof |
| 05/05/2009 | US7527808 Stability and dissolvability; for the therapy of an infectious disease |
| 05/05/2009 | US7527807 Compositions and methods for increasing the oral absorption of antimicrobials |
| 05/05/2009 | US7527806 Personal care article with distinct active zone |
| 05/05/2009 | US7527802 For therapy against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby |
| 05/05/2009 | US7527621 Implantable drug delivery device |
| 05/05/2009 | CA2436260C Compositions containing a ruthenium(iii) complex and a heterocycle |
| 05/05/2009 | CA2417764C Highly absorbable solid preparations containing sitafloxacin and tartaric acid |
| 05/05/2009 | CA2407854C Occlusive transdermal therapeutic system with a non-occlusive backing layer |
| 05/05/2009 | CA2382697C Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent |
| 05/05/2009 | CA2311450C Pharmaceutical aerosol compositions |
| 05/05/2009 | CA2309818C Buffered drug formulations for transdermal electrotransport delivery |
| 05/05/2009 | CA2265774C Antibacterial composition |
| 05/05/2009 | CA2233064C Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 05/05/2009 | CA2166394C Improved nicotine lozenge and therapeutic method for smoking cessation |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055794A1 Method and compositions for polymer nanocarriers containing therapeutic molecules |
| 04/30/2009 | WO2009055650A2 Polyacrylate nanoparticle drug delivery |
| 04/30/2009 | WO2009055637A2 Dehydrofluorination and surface modification of fluoropoymers for drug delivery applications |
| 04/30/2009 | WO2009055571A2 Methods of treating pulmonary disorders using liposomal vancomycin formulations |
| 04/30/2009 | WO2009055568A2 Liposomal vancomycin formulations |
| 04/30/2009 | WO2009055008A1 Two part lotion for the delivery of nitrite ions to the skin |
| 04/30/2009 | WO2009054992A1 Antimicrobial compositions comprising docusate |
| 04/30/2009 | WO2009054854A1 Loadable polymeric particles for bone augmentation and methods of preparing and using the same |
| 04/30/2009 | WO2009054841A2 Heat stable microcapsules and methods for making and using the same |
| 04/30/2009 | WO2009054743A1 Oral dosage forms comprising licarbazξpine acetate |
| 04/30/2009 | WO2009054550A1 Nifedipine-containing press coated tablet and method of preparing the same |
| 04/30/2009 | WO2009054432A1 Intraorally rapidly disintegrating pharmaceutical composition, and method for production thereof |
| 04/30/2009 | WO2009053994A1 Process for preparing pure amorphous quinapril hydrochloride |
| 04/30/2009 | WO2009053937A2 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 04/30/2009 | WO2009053900A1 Methods for preparing polymer microparticles |
| 04/30/2009 | WO2009053885A2 Methods for preparing polymer microparticles |
| 04/30/2009 | WO2009053824A1 Lipoic acid pellet composition |
| 04/30/2009 | WO2009053758A1 Anti-malarial pharmaceutical composition |
| 04/30/2009 | WO2009053718A2 Immuno-modulatory composition |
| 04/30/2009 | WO2009053711A2 Method of encapsulation |
| 04/30/2009 | WO2009053644A2 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 04/30/2009 | WO2009053601A2 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
| 04/30/2009 | WO2009053597A2 Novel method for preparing nanoparticles covered with an organic stabilising layer coupled to targeting ligands |
| 04/30/2009 | WO2009053596A2 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 04/30/2009 | WO2009053576A2 Coating composition comprising polydextrose, process for preparing same and use for coating ingestible solid forms |
| 04/30/2009 | WO2009053466A1 Long acting injectable formulations |
| 04/30/2009 | WO2009053106A1 Parathyroid hormone formulations and uses thereof |
| 04/30/2009 | WO2009052967A1 Apparatus and process for continuously producing spherical powder agglomerates |
| 04/30/2009 | WO2009052942A2 Stabilization of hydrophobic protein therapeutic agents |
| 04/30/2009 | WO2009052869A1 Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation |
| 04/30/2009 | WO2009052600A2 Extract of aleurites sp., process for obtaining the same and uses thereof |
| 04/30/2009 | WO2009030964A3 Amphiphilic oxalamide organogelators designed for gelation of organic solvents, water and hydrocarbon commercial fuels |
| 04/30/2009 | WO2009028900A3 Oral administration drug comprising clopidogrel besylate |
| 04/30/2009 | WO2009027644A8 Compositions for the treatment of neoplastic diseases |
| 04/30/2009 | WO2009027478A3 A method of removing preservatives from a liquid pharmaceutical preparation |
| 04/30/2009 | WO2009026461A3 Thermo-kinetic mixing for pharmaceutical applications |
| 04/30/2009 | WO2009021048A3 Microneedle arrays formed from polymer films |
| 04/30/2009 | WO2009021017A3 Nucleic acid-lipopolymer compositions |
| 04/30/2009 | WO2009019509A3 Improving skin barrier function |
| 04/30/2009 | WO2009016677A3 Continuous process for microspheres production by using expanded fluids |
| 04/30/2009 | WO2009009657A3 A composition to impart benefit agents to anionic substrates and methods of its use |
| 04/30/2009 | WO2009009115A3 Liposome compositions for treatment of hepatitis c |
| 04/30/2009 | WO2009009067A3 Micelle encapsulation of theropeutic agents |
| 04/30/2009 | WO2009007920A3 Delivery systems for delivering functional compounds to substrates and processes of using the same |
| 04/30/2009 | WO2008151022A3 Nucleic acid nanoparticles and uses therefor |
| 04/30/2009 | WO2008128342A9 Composition for enhancing bone formation |
| 04/30/2009 | WO2008124165A9 Self-assembling nanoparticle drug delivery system |
| 04/30/2009 | WO2008110813A3 Controlled release system |
| 04/30/2009 | WO2008102150A3 Composition for combating epistaxis |
| 04/30/2009 | WO2008073779A3 Compositions and methods for treating seizures |
| 04/30/2009 | WO2008068778A8 Extended release pharmaceutical composition of pramipexole |
| 04/30/2009 | WO2008066642A3 Transdermal delivery systems comprising bupivacaine |
| 04/30/2009 | WO2008060546A3 Oral formulations |
| 04/30/2009 | WO2008041970A3 Methods and compositions for targeting fenestrated vasculature |
| 04/30/2009 | WO2008015566A3 In-dwelling port for access into a body |
| 04/30/2009 | WO2007102090A3 Topical formulation |
| 04/30/2009 | WO2007056529A3 Remotely controlled substance delivery device |
| 04/30/2009 | WO2007056520A3 Osmotic pump with remotely controlled osmotic flow rate |
| 04/30/2009 | WO2007030698A3 Materials and methods for fabricating isolated micro-and nano-structures having chemical functionality |
| 04/30/2009 | WO2007029246A3 Food formulation for aquatic animals with integrated targeted delivery of bioactive agents |
| 04/30/2009 | WO2006099276A3 Biocompatible polymer compounds for medicinal formulations |
| 04/30/2009 | WO2006092789A3 Biodegradable self-inflating intragastric implants and method of curbing appetite by the same |
| 04/30/2009 | WO2006010083A3 Biodegradable nanoparticles |
| 04/30/2009 | US20090112189 Medical or veterinary digestive tract utilization systems and methods |
| 04/30/2009 | US20090112188 Device for controlling exposure of reservoir contents to surroundings |
| 04/30/2009 | US20090112181 Device and method for delivering or withdrawing a substance through the skin |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111831 Pharmaceutical compositions |
| 04/30/2009 | US20090111773 Compositions and methods of using lamellar bodies for modifying linear biological macromolecules |